Abstract
Electronic Fetal Heart Rate (FHR) monitoring is recommended to assess fetal well-being during labour in high risk pregnancies. This Cardiotocograph (CTG) monitoring relies on the ultrasound technology with the limitation of signal loss in 15% to 40% of the cases [1]. In the earlier versions of these CTG monitors, fetal heart tracings were generally of reasonable quality with many artefacts and some degree of occasional large signal noise. Subsequent models were improved by signal modulation and autocorrelation. Although, these new methodologies of signal processing have reduced the signal loss, the issues of inadvertent monitoring of the maternal heart rate as fetal heart rate and inaccurate evaluations of baseline fetal heart rate (i.e. doubling or halving) continue to pose difficulties during intrapartum fetal heart rate monitoring.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of Biomedical Research & Environmental Sciences
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
